3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Completed
4
Withdrawn
2
Not yet recruiting
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Carcinoma, Hepatocellular
2
Pancreatic Neoplasms
1
Liver Metastasis Colon Cancer
1
Liver Diseases
1
Interventions
lenvatinib
16
Bevacizumab
14
sintilimab
11
tislelizumab
9
apatinib
8
regorafenib
6
donafenib
6
camrelizumab
5
atezolizumab
4
Immune Checkpoint Inhibitors
4
Hepatectomy
4
durvalumab
3
Radiosurgery
3
Capecitabine
3
spartalizumab
2
pembrolizumab
2
cabozantinib
2
anlotinib
2
Specimen Handling
2
Oxaliplatin
2
Observation
2
Magnetic Resonance Spectroscopy
2
Injections
2
Immunotherapy
2
Folfox protocol
2
Fecal Microbiota Transplantation
2
Electroporation
2
Blood Specimen Collection
2
ursodoxicoltaurine
1
tremelimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Carcinoma, Hepatocellular
×
Electroporation
×
Clear all
NCT07191548
2025-10-10
LIVERMET-IRE
Angiodynamics, Inc.
Phase NA
Not yet recruiting
50 enrolled
NCT07192731
2025-10-10
LIVERHCC-IRE
Angiodynamics, Inc.
Phase NA
Not yet recruiting
50 enrolled